Glickman agrees, adding, Trulicity and Ozempic are both effective tools for managing type 2 diabetes, but semaglutide (Ozempic/Wegovy) stands out for its superior efficacy in both glycemic control and weight loss
Source: Polaris Market Research Analysis Industry Developments February 2025: Biocon launched its GLP-1 peptide liraglutide in the UK under two brand names: Liraglutide Biocon (for diabetes, similar to Victoza) and Biolide (for chronic weight management, similar to Saxenda)
Compounding for general weight loss, cost savings, or patient preference does not meet the legal criteria
Semaglutide + BPC-157 Peptide Therapy Combines the appetite-suppressing effects of Semaglutide with the healing and gut-protective benefits of BPC-157
Another reading suggests that broad gene-expression effects can reflect secondary consequences (changes in cell state, in proliferation rate, in metabolism) rather than direct mechanism-based effects, and that the specificity of the transcriptomic findings should be interpreted with caution